Nevertheless, this retrospective study found that addition of GABA, a DPP-4i and a PPI combination therapy (CT) to insulin therapy significantly improved glycemic control together with reduced insulin requirements in nineteen patients with T1D. This evidence concerns the gene INS and type 1 diabetes mellitus.